Molecular basics of sepsis development

Anaesthesiology Intensive Therapy

Volumn 44, Issue 4, 2012, Pages 221-225

  Jedynak, Monika ^a   Siemiatkowski, Andrzej ^a   Rygasiewicz, Karolina ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Inflammation; Innate immune response; Sepsis

Indexed keywords

CYTOKINE; BACTERIAL DNA; BACTERIUM LIPOPOLYSACCHARIDE; BIOLOGICAL FACTOR; GLUCAN; INFLAMMASOME; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 2; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 7; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LIPOTEICHOIC ACID; MANNAN; MITOGEN ACTIVATED PROTEIN KINASE; MYELOID DIFFERENTIATION FACTOR 88; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; PEPTIDOGLYCAN; POLYSACCHARIDE; PROTEIN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL RECEPTOR ASSOCIATED ACTIVATOR OF INTERFERON; TOLL RECEPTOR ASSOCIATED MOLECULE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VIRUS RNA;

APOPTOSIS; ARTICLE; BACTERIAL INFECTION; DISEASE COURSE; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; INFLAMMATION; INNATE IMMUNITY; INTENSIVE CARE UNIT; MACROPHAGE; MICROORGANISM; MOLECULAR DYNAMICS; NONHUMAN; SEPSIS; SIGNAL TRANSDUCTION; ANTIMICROBIAL ACTIVITY; BACTERIAL CELL WALL; CELL DAMAGE; CYTOKINE PRODUCTION; DAMAGE ASSOCIATED MOLECULAR PATTERN; HOST CELL; INFECTION PREVENTION; MEDIATOR RELEASE; MORBIDITY; MORTALITY; PATHOGEN ASSOCIATED MOLECULAR PATTERN; REVIEW; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

APOPTOSIS; HUMANS; IMMUNITY, INNATE; INFLAMMATION MEDIATORS; SEPSIS; SIGNAL TRANSDUCTION;

EID: 84878558852     PISSN: 16425758     EISSN: 17312531     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Kubler A, Mayzner-Zawadzka E, Durek G, Gaszyński W, Nestorowicz A, Karpel E: Prevalence and incidence of severe sepsis in intensive therapy units in Poland. Anaesthesiol Intensive Ther 2007; 39: 90-94.
2. Kubler A, Mayzner-Zawadzka E, Durek G, et al.: Results of severe sepsis treatment program using recombinant human activated protein C In Poland. Med Sci Monit 2006; 12: CR107-112. (Pubitemid 43332270)
3. Vincent JL, Sakr Y, Sprung CL, et al.: Sepsis occurrence in acutely ill patients investigators: Sepsis in european intensive care units: results of the SOAP Study. Crit Care Med 2006, 34: 344-353. (Pubitemid 43145611)
4. Janeway CA, Medzhitov R: Innate immune recognition. Annu Rev Immunol 2002; 20: 197-216. (Pubitemid 34293424)
5. Chudzicka A: Immunological mechanisms in pathogenesis of sepsis. Int Rev Allergol Clin Immunol 2007; 13: 74-79. (Pubitemid 350188251)
6. Cinel I, Opal SM: Molecular biology of inflammation and sepsis: A primer. Crit Care Med 2009; 37: 291-304.
7. Kawai T, Akira S: The roles of TLRs, RLRs and NLRs in pathogen recognition. Int Immunol 2009; 21: 317-337.
8. Paterson HM, Murphy TJ, Purcell EJ, et al.: Injury primes the innate immune system for enhanced Toll-like receptor reactivity. J Immunol 2003; 171: 1473-1483. (Pubitemid 36900082)
9. Wittebole X, Castanares-Zapatero D, Laterre PF: Toll-like receptor 4 modulation as a strategy to treat sepsis. Mediators Inflamm 2010; 2010: 568396.
10. Tidswell M, Tillis W, Larosa SP, et al.; Eritoran Sepsis Study Group: Phase 2 trial of eritoran tetrasodium (E5564), a toll-like receptor 4 antagonist, In patients with severe sepsis. Crit Care Med 2010; 38: 72-83.
11. Shaw PJ, Lamkanfi M, Kanneganti T-D: NOD-like receptor signaling beyond the inflammasome. Eur J Immunol 2010; 40: 624-627.
12. Shih VF-S, Tsui R, Caldwell A, Hoff mann A: A single NFkappaB system for both canonical and non-canonical signaling. Cell Res 2011; 21: 86-102.
13. Kato J, Yoneda-Kato N: Mammalian COP9 signalosome. Genes cells 2009; 14: 1209-1225.
14. Chopra M, Reuben JS, Sharma AC: Acute Lung Injury: apoptosis and signaling mechanisms. Exp Biol Med 2009; 234: 361-371.
15. Moine P, McIntyre R, Schwartz MD, et al.: NF-kappaB regulatory mechanisms in alveolar macrophages from patients with acute respiratory distress syndrome. Shock 2000; 13: 85-91.
16. Yang KY, Arcaroli JJ, Abraham E: Early alterations in neutrophil activation are associated with outcome in acute lung injury. Am J Resp Crit Care Med 2003; 167: 1567-1574. (Pubitemid 37363369)
17. Ogura Y, Sutterwala FS, Flavell RA: The inflammasome: first line of the immune response to cell stress. Cell 2006: 126: 659-662. (Pubitemid 44233635)
18. Giamarellos-Bourboulis EJ, van de Veerdonk FL, Mouktaroudi M, et al.: Inhibition of caspase-1 activation in gram-negative sepsis and experimental endotoxemia. Crit Care 2011; 15: R27.
19. Gibot S, Cravoisy A: Soluble form of the triggering receptor Expressem on myeloid cells-1 as a marker of microbial infection. Clin Med Res 2004; 2: 181-187.
20. Gibot S, Kolopp-Sarda MN, Bene MC, et al.: Plasma level of a triggering receptor expressed on myeloid cells-1: Its diagnostic accuracy in patients with suspected sepsis. Ann Intern Med 2004; 141: 9-15.
21. Cohen MJ, Brohi K, Calfee CS, et al.: Early relese of high mobility group box nuclear protein 1 after severe trauma in humans: role of injury severity and tissue hypoperfusion. Crit Care 2009; 13: R174.
22. Bopp C, Bierhaus A, Hofer S, et al.: Bench-to-bedside review: The inflammation-perpetuating pattern recognition receptor RAGE as a therapeutic target in sepsis. Crit Care 2008; 12: 201-208.
23. Wesche DE, Lomas-Neira JL, Perl M, Chung Ch-S, Ayala A: Lukocyte apoptosis and its significance in sepsis and shock. J Leukoc Biol 2005; 78: 325-337. (Pubitemid 41061305)
24. Power CP, Wang JH, Manning B, et al.: Bacterial lipoprotein delays apoptosisin human neutrophils through inhibition of caspase-3 activity: regulatory roles for CD14 and TLR2. J Immunol 2004; 173: 5229-5237. (Pubitemid 39387806)
25. Delogu G, Famularo G, Tellan G, et al.: Lymphocyte apoptosis, caspase activation and inflammatory response in septic shock. Infection 2008; 36: 485-487.
26. Weber SU, Schewe JC, Lehmann LE, et al.: Induction of Bim and Bid gene expression during accelerated apoptosis in severe sepsis. Crit Care 2008; 12: R128.
27. Peck-Palmer OM, Unsinger J, Chang KC, Davis CG, McDunn JE, Hotchkiss RS: Deletion of Myd88 markedly attenuates sepsis-induced T and B lymphocyte apoptosis but worsens survival. J Leukoc Biol 2008; 83: 1009-1018. (Pubitemid 351959882)
28. Chung CS, Venet F, Chen Y, Jones LN, Wilson DC, Ayala CA, Ayala A: Defi-ciency of Bid protein reduces sepsis-induced apoptosis, inflammation and improves septic survival. Shock 2010; 34: 150-161.